logo

For the Inventor, By the Inventor

Dortmund, Germany

Lead Discovery Center Gmbh


USPTO Granted Patents = 14



Forward Citations = 99

Loading Chart...
Loading Chart...

69 inventors (with patents filed for the assignee):

goldMedal Peter Nussbaumer (7 out of 8 patents)

silverMedal Uwe Koch (6 out of 18 patents)

bronzeMedal Jan Eickhoff (6 out of 8 patents)

4.  Axel Choidas (5 out of 6 patents)

5.  Bert Klebl (5 out of 6 patents)

6.  Gunther Zischinsky (5 out of 9 patents)

7.  Tim Bergbrede (4 out of 4 patents)

8.  Raffaella Di Lucrezia (3 out of 3 patents)

9.  Nils-Göran Larsson (3 out of 3 patents)

10.  Maria Falkenberg-Gustafsson (3 out of 3 patents)

11.  Claes M Gustafsson (3 out of 3 patents)

12.  Kiyean Nam (3 out of 7 patents)

13.  Jaeseung Kim (3 out of 12 patents)

14.  Yeejin Jeon (3 out of 5 patents)

15.  Dongsik Park (3 out of 6 patents)


14 patents:

1. 12281079 - Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer (2025-04-21),
2. 12060362 - Inhibitors of glucose transporters (GLUTs) (2024-08-13),
3. 11945822 - Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase (2024-04-02),
4. 11858937 - Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors (2024-01-02),
5. 11111238 - Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer (2021-09-07),
6. 10934274 - Quinoline derivatives as TAM RTK inhibitors (2021-03-02),
7. 10883137 - Method to detect activity of a polymerase (2021-01-05),
8. 10703735 - 4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer (2020-07-07),
9. 9567345 - Pharmaceutically active pyrazolo-triazine derivatives (2017-02-14),
10. 9453051 - Cyclosporin derivatives (2016-09-27),
11. 9242937 - Pharmaceutically active disubstituted pyridine derivatives (2016-01-26),
12. 9096608 - Pharmaceutically active pyrazolo-triazine derivatives (2015-08-04),
13. 8999982 - Pharmaceutically active compounds as Axl inhibitors (2015-04-07),
14. 8084457 - Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases (2011-12-27),
Lead Discovery Center GmbH (LDC) is a translational research center that focuses on the discovery and development of novel drug candidates. LDC collaborates with academic institutions and industrial partners to identify promising drug discovery projects and translate them into innovative therapies. The center offers expertise in medicinal chemistry, biochemistry, and in vitro and in vivo pharmacology to accelerate the development of new pharmaceuticals.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
14 Patents

#23 in Dortmund

#2,894 in Germany

#40,903 in the World

...
Dortmund, Germany

Lead Discovery Center Gmbh

Forward Citations = 99

69 inventors:

goldMedal Peter Nussbaumer (7 out of 8 patents)

silverMedal Uwe Koch (6 out of 18 patents)

bronzeMedal Jan Eickhoff (6 out of 8 patents)

4.  Axel Choidas (5 out of 6 patents)

5.  Bert Klebl (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com
Loading…